KELM - Kreatives. Kunst. Büro. ▷ Bastelbedarf, Handarbeitsbedarf Einzelhandel in Bad Nauheim - Öffnungszeiten
![Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness | SpringerLink Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00392-021-01841-y/MediaObjects/392_2021_1841_Figa_HTML.png)
Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness | SpringerLink
![Incidence and Predictors of Target Vessel Revascularization and Clinical Event Rates of the Sirolimus-Eluting Coronary Stent (Results from the Prospective Multicenter German Cypher Stent Registry) - American Journal of Cardiology Incidence and Predictors of Target Vessel Revascularization and Clinical Event Rates of the Sirolimus-Eluting Coronary Stent (Results from the Prospective Multicenter German Cypher Stent Registry) - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2003220333/2012902482/gr1.gif)
Incidence and Predictors of Target Vessel Revascularization and Clinical Event Rates of the Sirolimus-Eluting Coronary Stent (Results from the Prospective Multicenter German Cypher Stent Registry) - American Journal of Cardiology
![Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870322000102-gr1b.jpg)
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial - ScienceDirect
![Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut - International Journal of Cardiology Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a670f58d-683b-45c8-ad79-0966abb7755c/gr1_lrg.jpg)
Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut - International Journal of Cardiology
![IJMS | Free Full-Text | Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models | HTML IJMS | Free Full-Text | Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models | HTML](https://www.mdpi.com/ijms/ijms-23-07611/article_deploy/html/images/ijms-23-07611-g001.png)